期刊文献+

卡铂长循环脂质体的制备及其在大鼠体内的药动学

Preparation and Pharmacokinetics in Rats of Carboplatin Long-circulating Liposomes
原文传递
导出
摘要 该研究采用被动载药的方式制备了分别含卡铂20和10 mg/ml的卡铂长循环脂质体A、B,对其理化性质进行了分析,并应用原子吸收光谱法测定血浆中的药物浓度以评价其在SD大鼠体内的药动学行为。研究结果表明,制得的卡铂脂质体分散性、流动性、重现性良好,粒径约为100 nm。卡铂长循环脂质体A、B的AUC分别为(1667.87±642.98)和(1359.43±583.61)h·mg·L^(-1),c_(max)分别为(96.72±27.21)和(63.04±22.15)mg/L,t_(1/2)分别为(15.02±5.72)和(22.90±5.64)h,在同等给药剂量下与游离药物组相比,均显著提高。卡铂长循环脂质体可延长药物在血液中的循环时间,有利于提高药物在肿瘤组织中的浓度,进而增强疗效,有望为卡铂新剂型的研究提供思路和参考。 In this study,carboplatin long-circulating liposomes A(20 mg/ml)and B(10 mg/ml)were prepared by passive drug loading,and their physicochemical properties were analyzed.The plasma drug concentration was determined by atomic absorption spectrometry to evaluate the pharmacokinetics in rats.The results showed that the prepared carboplatin liposomes had good dispersibility,fluidity and reproducibility,and the particle size was about 100 nm.The AUC of carboplatin long-circulating liposomes A and B were(1667.87±642.98)and(1359.43±583.61)h·mg·L^(-1),respectively,and the c_(max) were(96.72±27.21)and(63.04±22.15)mg/L,respectively,t_(1/2) were(15.02±5.72)and(22.90±5.64)h,which were significantly increased compared with the free drug group at the same dose.Carboplatin long-circulating liposomes can prolong the circulation time of the drug in the blood,which is beneficial to increase the drug concentration in the tumor tissue,thereby enhancing the curative effect.This study provided ideas and references for researching new carboplatin dosage forms.
作者 问天娇 李思颖 李蝉 张欣娜 崔京霞 WEN Tianjiao;LI Siying;LI Chan;ZHANG Xinna;CUI Jingxia(Dept.of Pharmacy,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011;CSPC Zhong Qi Pharmaceutical Technology Co.,Ltd.,Shijiazhuang 050035;Key Lab.of Innovative Drug Development and Evaluation,School of Pharmacy,Hebei Medical University,Shijiazhuang 050011)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2022年第9期1286-1291,共6页 Chinese Journal of Pharmaceuticals
基金 河北省医学科学研究重点课题计划项目(20221279)、河北省应用基础研究计划重点基础研究项目(12966417D)、河北省自然科学基金(H2012206039)。
关键词 卡铂 长循环脂质体 原子吸收光谱法 药动学 carboplatin long-circulating liposome atomic absorption spectrometry pharmacokinetics
  • 相关文献

参考文献5

二级参考文献74

  • 1VEAL G J, DIAS C, PRICE L, et al. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy[J]. Clin Cancer Res, 2001,7 (8) :2205-2212.
  • 2LOPEZ-FLORES A, JURADO R, GARCIA-LOPEZ P. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples[J]. J Pharmacol Toxicol Methods, 2005,52(3) :366-372.
  • 3LANJWANI S N, ZHU R, KHUHAWAR M Y, et al. High performance liquid chromatographic determination of platinum in blood and urine samples of cancer patients after administration of cisplatin drug using solvent extraction and N, N'-bis(salicylidene)-1, 2-propanediamine as complexation reagent[J]. J Pharm Biomed Anal, 2006,40(4):833-839.
  • 4GELEVERT T, MESSERSCHMIDT J, MAEINAR- DI M T, et al. Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin[J]. Ther Drug Monit, 2001,23(2) : 169-173.
  • 5HUANG Z, TIMERBAEV A R, KEPPLER B K, et al. Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques[J]. J Chromatogr A, 2006,1106(1/2) :75-79.
  • 6PENDYALA L, SCHWARTZ G, SMITH P, et al. Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy[J]. Cancer Chemother Pharmacol, 2003, 51 (5) : 376-384.
  • 7ZAMBONI W C, GERVAIS A C, EGORIN M J, et al. Inter-and intratumoral disposition of platinum in solid tumors after administration of cisplatin[J]. Clin Cancer Res, 2002,8(9) : 2992-2999.
  • 8ROSENBERG B,VANCAMP L.Platinum compounds:a new class of potent antitumour agents[J].Nature,1969,222(5191):385-386.
  • 9HARPER B W,KRAUSE-HEUER A M,Grant M P,et al.Advances in platinum chemotherapeutics[J].Chemistry-A European Journal,2010,16(64):7064-7077.
  • 10WHEATE N J,WALKER S,CRAIG G E,et al.The status of platinum anticancer drugs in the clinic and in clinical trials[J].Dalton Transactions,2010,39(35):8113-8127.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部